Impact of Ligilactobacillus salivarius Li01 on benzo[a]pyrene-induced colitis, based on host-microbiome interactions in Mongolian gerbils
Authors:
Open Access
- 26 February 2025
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Nutrition
- Vol. 12, 1494525
Abstract
Background: Probiotics supplementations have been regarded as an effective strategy for colitis treatment. However, the effect of Ligilactobacillus salivarius Li01 on benzo[a]pyrene (BaP)-induced colitis in Mongolian gerbils remains unclear. In this study, we leverage a BaP-induced model of colitis that exhibits significant remission following Ligilactobacillus salivarius Li01 intervention, to conduct an animal experiment that integrates histopathological assessment, inflammatory cytokines, 16S rRNA sequencing, targeted metabolomic profiling to investigate the relationship between Ligilactobacillus salivarius Li01, gut microbiota, and colitis.Results: We demonstrated that the improvements in colon histopathological assessment and inflammatory cytokines by Ligilactobacillus salivarius Li01 supplementation are accompanied by alterations in gut microbiota structure marked by increased abundance of strains with probiotic potential belonging to Bifidobacterium and Eubacterium_coprostanoligenes. Targeted metabolomic profiling analysis showed that Ligilactobacillus salivarius Li01 supplementation increases the concentration of acetic, propionic, butyric, and valeric acid. Correlation analysis showed that the alteration in the indicators associated with colitis is closely correlated to the changed microbial taxa and short-chain fatty acids (SCFAs).Conclusion: These data highlighted that Ligilactobacillus salivarius Li01 supplementation ameliorated the BaP-induced colitis, probably via modulating the structure of gut microbiota and promoting the production of SCFAs. Our findings provide preliminary evidence for a possible therapeutic strategy for the treatment of colitis based on host-microbiome interactions.Keywords
This publication has 53 references indexed in Scilit:
- Polysaccharides from Lycium barbarum, yam, and sunflower ameliorate colitis in a structure and intrinsic flora-dependent mannerCarbohydrate Polymers, 2024
- The role of probiotic supplementation in inflammatory biomarkers in adults: an umbrella meta-analysis of randomized controlled trialsInflammopharmacology, 2023
- Implications of the changing epidemiology of inflammatory bowel disease in a changing worldUnited European Gastroenterology Journal, 2022
- Ligilactobacillus salivarius functionalities, applications, and manufacturing challengesApplied Microbiology and Biotechnology, 2021
- Short chain fatty acids and its producing organisms: An overlooked therapy for IBD?EBioMedicine, 2021
- Clinical effects and gut microbiota changes of using probiotics, prebiotics or synbiotics in inflammatory bowel disease: a systematic review and meta-analysisEuropean Journal of Nutrition, 2021
- Induction and maintenance treatment of inflammatory bowel disease: A comprehensive reviewAutoimmunity Reviews, 2019
- Probiotics are a good choice in remission of inflammatory bowel diseases: A meta analysis and systematic reviewJournal of Cellular Physiology, 2017
- The Treatment-Naive Microbiome in New-Onset Crohn’s DiseaseCell Host & Microbe, 2014
- Disease phenotype and genotype are associated with shifts in intestinal-associated microbiota in inflammatory bowel diseasesInflammatory Bowel Diseases, 2011